Search - tctmd.com

Displaying 221 - 240 of 571

Sort: Relevancy | Date

Presentation TCT 2017

Are All Contemporary DES Comparable? Lessons From the SCAAR Registry

Presenter: Giulio G. Stefanini, Stephan Windecker, Stefan K. James

October 30, 2017

Presentation TCT 2017

Are All Contemporary DES Comparable? Lessons From the COMPARE Trials

Presenter: Giulio G. Stefanini, Stephan Windecker, Elvin Kedhi

October 30, 2017

Presentation TCT 2017

Are All Contemporary DES Comparable? Lessons From the TWENTE Trials

Presenter: Giulio G. Stefanini, Stephan Windecker, Clemens von Birgelen

October 30, 2017

Presentation TCT 2017

Are All Contemporary DES Comparable? Lessons From the SORT-OUT Trials

Presenter: Giulio G. Stefanini, Stephan Windecker, Evald H. Christiansen

October 30, 2017

Presentation TCT 2017

Are There Meaningful Differences Between Current Durable Polymer-Based vs Bioabsorbable Polymer-Based vs Polymer-Free Metallic DES? Pathologic Insights

Presenter: Giulio G. Stefanini, Stephan Windecker, Renu Virmani

October 30, 2017

Presentation TCT 2017

Mortality and Stroke After PCI vs CABG In Left Main and 3VD: An Individual Patient Data Meta-analysis

Presenter: Dean J. Kereiakes, Spencer B. King III, A. Pieter Kappetein

October 30, 2017

Presentation TCT 2017

Influence of Diversity: Should Sex, Race, and Ethnicity Affect Revascularization Decisions? Does It?

Presenter: Dean J. Kereiakes, Spencer B. King III, Roxana Mehran

October 30, 2017

Presentation TCT 2017

Impact of Mandatory Stent Price Controls 2: My New Insights From Inside Industry

Presenter: Dean J. Kereiakes, Spencer B. King III, Ian T. Meredith

October 30, 2017

Presentation TCT 2017

Impact of Mandatory Stent Price Controls 1: Physician Perspectives

Presenter: Dean J. Kereiakes, Spencer B. King III, Upendra Kaul

October 30, 2017

Presentation TCT 2017

Impact of AUC and Public Reporting: Is PCI Now More Appropriate?

Presenter: Dean J. Kereiakes, Spencer B. King III, Michael A. Kutcher

October 30, 2017

Presentation TCT 2017

Metallic DES: What Can We Expect From New Drugs, Polymers, and Metals? Have We Reached the Limit of Iterative Development?

Presenter: Dean J. Kereiakes, Spencer B. King III, Elazer R. Edelman

October 30, 2017

Presentation TCT 2017

New Insights Into Neoatherosclerosis and Other Causes of Metallic Stent Thrombosis: Will the Most Dreaded Complication Always Be With Us?

Presenter: Dean J. Kereiakes, Spencer B. King III, Aloke V. Finn

October 30, 2017

Presentation TCT 2017

Is There a Need for Dedicated Bifurcation Stents (Bare Metal or Drug-Eluting)?

Presenter: Alaide Chieffo, Jeffrey W. Moses, Martin B. Leon

October 30, 2017

Presentation TCT 2017

Very Late Stent Failures and Non-Stent Related Events: Insights Into Improving Event-Free Survival

Presenter: Dean J. Kereiakes, Spencer B. King III, Lorenz Raber

October 30, 2017

Presentation TCT 2017

Keynote Lecture: A Brief 40-Year History of PCI - How Far We've Come, How Far We Have to Go

Presenter: Dean J. Kereiakes, Spencer B. King III, Robert A. Byrne

October 30, 2017

Presentation TCT 2017

DARE: A Randomized Trial of a Drug-Eluting Balloon vs a Metallic DES in Patients With Coronary Artery In-Stent Restenosis

Presenter: Fernando Alfonso, Jose P.S. Henriques

October 30, 2017

Presentation TCT 2017

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Binita Shah

October 29, 2017

Presentation TCT 2017

Drug-Eluting Stent Platforms and Outcomes 2017

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Gennaro Sardella

October 29, 2017

Presentation iASSESS 2017

New Generation Drug Eluting Stents & Bioabsorbable Vascular Scaffolds: Indications, Outcomes, & Complications

Presenter: Rajesh V. Swaminathan, Dmitriy N. Feldman

August 30, 2017

Presentation Fellows 2017

The Evolution of Drug-Eluting Stents

Presenter: Ajay J. Kirtane

April 07, 2017

Advertisement

Are All Contemporary DES Comparable? Lessons From the SCAAR Registry

Are All Contemporary DES Comparable? Lessons From the COMPARE Trials

Are All Contemporary DES Comparable? Lessons From the TWENTE Trials

Are All Contemporary DES Comparable? Lessons From the SORT-OUT Trials

Are There Meaningful Differences Between Current Durable Polymer-Based vs Bioabsorbable Polymer-Based vs Polymer-Free Metallic DES? Pathologic Insights

Mortality and Stroke After PCI vs CABG In Left Main and 3VD: An Individual Patient Data Meta-analysis

Influence of Diversity: Should Sex, Race, and Ethnicity Affect Revascularization Decisions? Does It?

Impact of Mandatory Stent Price Controls 2: My New Insights From Inside Industry

Impact of Mandatory Stent Price Controls 1: Physician Perspectives

Impact of AUC and Public Reporting: Is PCI Now More Appropriate?

Metallic DES: What Can We Expect From New Drugs, Polymers, and Metals? Have We Reached the Limit of Iterative Development?

New Insights Into Neoatherosclerosis and Other Causes of Metallic Stent Thrombosis: Will the Most Dreaded Complication Always Be With Us?

Is There a Need for Dedicated Bifurcation Stents (Bare Metal or Drug-Eluting)?

Very Late Stent Failures and Non-Stent Related Events: Insights Into Improving Event-Free Survival

Keynote Lecture: A Brief 40-Year History of PCI - How Far We've Come, How Far We Have to Go

DARE: A Randomized Trial of a Drug-Eluting Balloon vs a Metallic DES in Patients With Coronary Artery In-Stent Restenosis

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Drug-Eluting Stent Platforms and Outcomes 2017

New Generation Drug Eluting Stents & Bioabsorbable Vascular Scaffolds: Indications, Outcomes, & Complications

The Evolution of Drug-Eluting Stents

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content